Pricing

Precision BioSciences Inc (DTIL)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Michael Amoroso
Employees:
200
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
919-314-5512
Stock Split History
DateRatio
2024-02-14 1:30
Precision BioSciences offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which a specific type of immune cell, called a T cell, is genetically engineered to recognize and kill cancer cells. PBCAR0191, which is in Phase 1/2a clinical trial in adult patients with NHL or R/R B-cell precursor acute lymphoblastic leukemia, or B-ALL.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available